Coatue Management’s Medifast MED Stock Holding History

Coatue Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,799	Closed	-$357K	–	187
2019 Q1	$357K	Buy	+2,799	New	+$355K	﹤0.01%	87
2018 Q4	–	Sell	-4,196	Closed	-$930K	–	132
2018 Q3	$930K	Sell	4,196 -1,838	-30%	-$373K	0.01%	50
2018 Q2	$967K	Buy	+6,034	New	+$771K	0.01%	33

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Coatue Management's MED Position: Q2 2019 in Review

Coatue Management sold out of Medifast (MED) in Q2 2019, closing a stake of 2,799 shares — an estimated $357K sold.

Coatue Management first reported a position in MED in Q2 2018 and held it in 3 quarters. The position peaked at $967K in Q2 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

Coatue Management reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
Coatue Management sold 2,799 Medifast shares in Q2 2019, an estimated $357K.
Coatue Management first reported a position in Medifast in Q2 2018 and held it in 3 quarters.
Coatue Management's Medifast position peaked at $967K in Q2 2018.
251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on Coatue Management's 13F filing for Q2 2019, filed 14 Aug 2019.